Pividl Bioscience Inc.

$75,000.00 CAD

≈ 12 months of average Canadian pay
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2025-2026
Agreement period
June 1, 2025 – February 28, 2026
Reference
nrc-cnrc:172-2025-2026-Q1-1031138

Published purpose

Pividl's Micellosomes are a novel nano-delivery system used to deliver hard to solubilize and poorly bioavailable compounds. This project is aimed at demonstrating how Micellosomes can be used to deliver anti-inflammatory molecules that have the potential to provide radiation protection and reduce the impacts of radiation / inflammation exposure on and in the human body. Formulations produced will be standardised and validated for stability, encapsulation efficiency and bioavailability kinetics in order to demonstrate their ability to prevent and reduce radiation induced inflammation in Microvascular endothelial cells and anti-inflammatory responses in human Embryonic kidney cells, cardiovascular cells and blood-brain-barrier cells.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions